The markets opened mixed with the Dow falling 33 points to 19,793 while Nasdaq rose 14 points to 5,553 as the consumer price index edged up 0.3% in December.
On the upside
Mexico granted market approval to Apricus Biosciences' (Nasdaq: APRI) erectile dysfunction treatment Vitaros.
CoLucid Pharmaceuticals (Nasdaq: CLCD) will be acquired by Eli Lilly (Nasdaq: LLY) for a premium of approximately $960 million in cash.
NXT-ID (Nasdaq: NXTD) reported sharply higher preliminary fourth quarter revenue.
On the downside
Gigamon (NYSE: GIMO) warned that fourth quarter revenue would fall short of expectations.
Cameco (NYSE: CCJ) reported preliminary 2016 earnings that missed analyst estimates by a wide margin and announced job cuts.
Investors locked in profits on Pulmatrix (Nasdaq: PULM).
In the broad market, declining issues barely edged out advancers by a slim margin on the NYSE while advancers outpaced decliners by more than 10 to 9 on Nasdaq. The broader S&P 500 index added a point to 2,269. Bitcoin tumbled $36 to $861.
